Robert W. Baird analyst Brian Skorney maintained a Buy rating on Soleno Therapeutics (SLNO – Research Report) on November 6 and set a ...

Aligos Therapeutics, Inc. ( (ALGS) ) has released its Q3 earnings. Here is a breakdown of the information Aligos Therapeutics, Inc. presented ...

In a related JAMA Viewpoint, the authors noted that COVID-19 peaked in 2020 and 2021 as the third highest cause of mortality ...

Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Despite a dip in revenue, Arcturus Therapeutics Holdings Inc (ARCT) celebrates a successful vaccine launch in Japan and ...

Crispr Therapeutics recently received FDA and EMA approval for Casgevy. Read why CRSP stock is compelling investment in the ...

“Although randomized clinical trials are normally used to approve therapeutics, the federal government has not required COVID ...

A critical challenge during the early COVID-19 pandemic was determining whether a patient would survive the infection or die ...

Good afternoon and welcome to Arcturus Therapeutics quarterly financial update and pipeline ... our self-amplifying mRNA COVID-19 vaccine. We're thrilled about our recent commercial launch of KOSTAIVE ...

MiNK Therapeutics (MiNK, NASDAQ: INKT), a clinical-stage company pioneering the development of allogeneic off-the-shelf, invariant natural killer T (iNKT) cell therapies, today ...

Flush with cash from its coronavirus success ... that it acquired in its $5.4 billion purchase of Global Blood Therapeutics, citing patient deaths. “It’s hard to find a headline that ...